GRK2 and atherosclerosis: This study utilized large‐scale phosphoproteomics, transgenic mice, and numerous molecular biology techniques to illustrate that OSS increases the level of GRK2 phosphorylated at serine 29 (GRK2S29p) in vascular endothelial cells, thereby promoting AP‐1 phosphorylation and contributing to atherosclerosis.